Progress in Diabetes: A Guide for Endocrinologists and Physicians | Diabetes Technology, AI-driven Care, Genetics, Precision Medicine, New Therapies, ... Diabetes Trends & Complication Management: 1

Progress in Diabetes is a comprehensive, future-focused reference edited by Dr Anuj Maheshwari (President, RSSDI 2025-2026) and Dr Shambo Samrat Samajdar, tracking the current state of the art across 29 chapters. It moves from the global epidemiology, genetics and epigenetics of diabetes and immunotherapy in type 1 diabetes through to today's therapeutic innovations -- beta-cell regeneration, new drug classes including SGLT2 inhibitors and GLP-1/GIP dual agonists, precision medicine, and surgical and weight-loss approaches to remission. A dedicated section covers technology-driven diabetes care, including AI-based predictive analytics, wearables and continuous glucose monitoring, closed-loop insulin delivery, telemedicine and big-data-powered research. The book closes with complication management (cardiovascular, renal, retinal and neuropathic), psychosocial support, lifestyle intervention, diabetes in special populations, and policy and equity chapters addressing global disparities in diabetes care -- illustrated throughout with original diagrams, flowcharts and landmark RCT data (Da Qing Study, Finnish DPS, Indian Diabetes Prevention Program, ICMR-INDIAB). Who This Book Is For: Diabetologists and Endocrinologists: a single volume tracking the therapeutic, technological and research advances shaping current diabetes practice. Postgraduate Medical Students and Fellows in Endocrinology: chapter-by-chapter academic coverage of pharmacotherapy, genetics and complication management for exam and clinical preparation. General Physicians: practical guidance on newer drug classes, remission strategies and complication screening for day-to-day diabetes management. Clinical Researchers and Academicians: summaries of landmark RCTs, emerging biomarkers and AI and big-data research directions in diabetes. Why This Book Helps: Keeps prescribing current: dedicated chapters on SGLT2 inhibitors, GLP-1/GIP dual agonists and precision medicine translate the newest drug classes into practical guidance. Bridges technology into practice: chapters on AI-driven care, continuous glucose monitoring, closed-loop insulin delivery and telemedicine explain how digital tools are changing day-to-day management. Addresses the whole patient: dedicated chapters on cardiovascular, renal, retinal, neuropathic and psychosocial complications support comprehensive, not just glycemic, care. Contextualizes the evidence: summaries of landmark RCTs and India-specific data (ICMR-INDIAB) connect global trial evidence to Indian clinical practice. Looks beyond glycemic control: dedicated chapters link diabetes to cancer risk, the microbiome and sports medicine, broadening the clinical picture for complex patients. Key Features: 29 chapters covering the full breadth of diabetes care, from epidemiology and genetics through therapeutics, technology and complications. Dedicated coverage of newer drug classes -- SGLT2 inhibitors, GLP-1 receptor mono-agonists and GLP-1/GIP dual agonists -- and precision-medicine approaches to treatment tailoring. Technology-focused chapters on AI-driven predictive analytics, continuous glucose monitoring, closed-loop insulin delivery and telemedicine. Boxed chapter abstracts and keyword panels with original explanatory diagrams and flowcharts throughout. Landmark RCT summaries (Da Qing Study, Finnish DPS, Indian Diabetes Prevention Program) alongside India-specific epidemiological data (ICMR-INDIAB).

Disclaimer:

• Progress in Diabetes: A Guide for Endocrinologists and Physicians | Diabetes Technology, AI-driven Care, Genetics, Precision Medicine, New Therapies, ... Diabetes Trends & Complication Management: 1 book is not for reading online or for free download in PDF or eBook format.
• Table of Contents, Index, Syllabus, summary and image of Progress in Diabetes: A Guide for Endocrinologists and Physicians | Diabetes Technology, AI-driven Care, Genetics, Precision Medicine, New Therapies, ... Diabetes Trends & Complication Management: 1 may be of a different edition or of the same title.
• Price can change due to reprinting, price change by publisher or sourcing cost change for imported books.